Clopidogrel after asymptomatic perioperative troponin release in major vascular surgery

Phase 3, randomised, open-label trial of clopidogrel in acute coronary syndrome (ACS), cardiac ischemia and arteriosclerosis obliterans (2 arms), sponsored by Erasmus MC. Primary endpoints: Composite of major cardiovascular and severe ischemic events, Unstable angina with ECG changes and 6 more. Started Apr 2009; status: active, not recruiting.